vs
FIRST CAPITAL INC（FCAP）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是FIRST CAPITAL INC的1.4倍（$19.6M vs $13.5M），FIRST CAPITAL INC净利率更高（36.2% vs -177.4%，领先213.6%），FIRST CAPITAL INC同比增速更快（19.0% vs -11.5%），FIRST CAPITAL INC自由现金流更多（$19.9M vs $-23.1M），过去两年FIRST CAPITAL INC的营收复合增速更高（13.4% vs -12.2%）
First Capital曾用名Future Capital Holdings，是印度一家非银行金融机构，主营债务融资业务。2018年12月，该机构与IDFC银行合并，组建IDFC第一银行，合并前其股票在印度国家证券交易所和孟买证券交易所挂牌上市。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FCAP vs LAB — 直观对比
营收规模更大
LAB
是对方的1.4倍
$13.5M
营收增速更快
FCAP
高出30.4%
-11.5%
净利率更高
FCAP
高出213.6%
-177.4%
自由现金流更多
FCAP
多$43.0M
$-23.1M
两年增速更快
FCAP
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $19.6M |
| 净利润 | $4.9M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 36.2% | -177.4% |
| 营收同比 | 19.0% | -11.5% |
| 净利润同比 | 49.6% | -28.8% |
| 每股收益（稀释后） | $1.45 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCAPLAB
| Q4 25 | $13.5M | — | ||
| Q3 25 | $13.3M | $19.6M | ||
| Q2 25 | $12.4M | $21.8M | ||
| Q1 25 | $11.4M | $40.8M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $10.9M | $22.1M | ||
| Q2 24 | $10.7M | $22.5M | ||
| Q1 24 | $10.5M | $45.5M |
净利润FCAPLAB
| Q4 25 | $4.9M | — | ||
| Q3 25 | $4.5M | $-34.7M | ||
| Q2 25 | $3.8M | $-33.5M | ||
| Q1 25 | $3.2M | $-26.0M | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $2.9M | $-26.9M | ||
| Q2 24 | $2.8M | $-45.7M | ||
| Q1 24 | $3.0M | $-32.2M |
毛利率FCAPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率FCAPLAB
| Q4 25 | — | — | ||
| Q3 25 | 41.8% | -168.5% | ||
| Q2 25 | 37.2% | -118.1% | ||
| Q1 25 | 34.2% | -80.8% | ||
| Q4 24 | 34.8% | — | ||
| Q3 24 | 31.5% | -120.9% | ||
| Q2 24 | 31.1% | -134.5% | ||
| Q1 24 | 33.0% | -132.2% |
净利率FCAPLAB
| Q4 25 | 36.2% | — | ||
| Q3 25 | 33.8% | -177.4% | ||
| Q2 25 | 30.4% | -153.7% | ||
| Q1 25 | 28.3% | -63.8% | ||
| Q4 24 | 28.8% | — | ||
| Q3 24 | 26.5% | -122.0% | ||
| Q2 24 | 26.5% | -203.3% | ||
| Q1 24 | 28.1% | -70.6% |
每股收益（稀释后）FCAPLAB
| Q4 25 | $1.45 | — | ||
| Q3 25 | $1.34 | $-0.09 | ||
| Q2 25 | $1.13 | $-0.09 | ||
| Q1 25 | $0.97 | $-0.07 | ||
| Q4 24 | $0.97 | — | ||
| Q3 24 | $0.87 | $-0.07 | ||
| Q2 24 | $0.85 | $-0.12 | ||
| Q1 24 | $0.88 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $137.8M | $399.7M |
| 总资产 | $1.3B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FCAPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务FCAPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益FCAPLAB
| Q4 25 | $137.8M | — | ||
| Q3 25 | $132.4M | $399.7M | ||
| Q2 25 | $123.2M | $424.5M | ||
| Q1 25 | $120.1M | $454.6M | ||
| Q4 24 | $114.6M | — | ||
| Q3 24 | $116.8M | $489.3M | ||
| Q2 24 | $107.8M | $510.3M | ||
| Q1 24 | $105.7M | $577.3M |
总资产FCAPLAB
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $539.6M | ||
| Q2 25 | $1.2B | $557.0M | ||
| Q1 25 | $1.2B | $579.6M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | $681.5M | ||
| Q2 24 | $1.2B | $708.7M | ||
| Q1 24 | $1.2B | $777.7M |
负债/权益比FCAPLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $19.9M | $-23.1M |
| 自由现金流率自由现金流/营收 | 147.7% | -118.1% |
| 资本支出强度资本支出/营收 | 10.0% | 4.5% |
| 现金转化率经营现金流/净利润 | 4.36× | — |
| 过去12个月自由现金流最近4个季度 | $35.3M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FCAPLAB
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.9M | $-22.2M | ||
| Q2 25 | $3.7M | $-20.7M | ||
| Q1 25 | $4.4M | $-30.3M | ||
| Q4 24 | $22.3M | — | ||
| Q3 24 | $7.6M | $-27.9M | ||
| Q2 24 | $3.5M | $-39.0M | ||
| Q1 24 | $7.2M | $-62.5M |
自由现金流FCAPLAB
| Q4 25 | $19.9M | — | ||
| Q3 25 | $7.8M | $-23.1M | ||
| Q2 25 | $3.5M | $-22.6M | ||
| Q1 25 | $4.2M | $-35.3M | ||
| Q4 24 | $21.6M | — | ||
| Q3 24 | $7.5M | $-30.1M | ||
| Q2 24 | $3.3M | $-41.0M | ||
| Q1 24 | $7.1M | $-63.3M |
自由现金流率FCAPLAB
| Q4 25 | 147.7% | — | ||
| Q3 25 | 58.6% | -118.1% | ||
| Q2 25 | 27.8% | -103.6% | ||
| Q1 25 | 36.5% | -86.6% | ||
| Q4 24 | 190.7% | — | ||
| Q3 24 | 68.6% | -136.4% | ||
| Q2 24 | 31.2% | -182.2% | ||
| Q1 24 | 67.2% | -138.9% |
资本支出强度FCAPLAB
| Q4 25 | 10.0% | — | ||
| Q3 25 | 1.2% | 4.5% | ||
| Q2 25 | 2.2% | 8.7% | ||
| Q1 25 | 1.9% | 12.4% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 0.8% | 10.2% | ||
| Q2 24 | 1.4% | 8.6% | ||
| Q1 24 | 1.5% | 1.7% |
现金转化率FCAPLAB
| Q4 25 | 4.36× | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 6.84× | — | ||
| Q3 24 | 2.62× | — | ||
| Q2 24 | 1.23× | — | ||
| Q1 24 | 2.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCAP
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
